115 related articles for article (PubMed ID: 3919197)
1. Effects of nonsteroidal antiestrogens, analog II and tamoxifen, on a metastatic transplantable rat mammary tumor.
King MM; Magarian RA; Terao J; Brueggemann GL
J Natl Cancer Inst; 1985 Feb; 74(2):447-51. PubMed ID: 3919197
[TBL] [Abstract][Full Text] [Related]
2. The interaction of dietary fat and antiestrogen treatment on DMBA-induced mammary tumors in the rat.
King MM; Pento JT; Magarian RA; Brueggemann G
Nutr Cancer; 1985; 7(4):239-49. PubMed ID: 3938837
[TBL] [Abstract][Full Text] [Related]
3. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
4. Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.
Ben-Hur H; Kossoy G; Zusman I
Int J Oncol; 2002 Feb; 20(2):413-7. PubMed ID: 11788910
[TBL] [Abstract][Full Text] [Related]
5. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
6. NTP Studies of Magnetic Field Promotion (DMBA Initiation) in Female Sprague-Dawley Rats (Whole-body Exposure/Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Aug; 489():1-148. PubMed ID: 12563342
[TBL] [Abstract][Full Text] [Related]
7. Influence of dietary fat and indomethacin on the growth of transplantable mammary tumors in rats.
Kollmorgen GM; King MM; Kosanke SD; Do C
Cancer Res; 1983 Oct; 43(10):4714-9. PubMed ID: 6576855
[TBL] [Abstract][Full Text] [Related]
8. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
[TBL] [Abstract][Full Text] [Related]
9. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
Gottardis MM; Jordan VC
Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
11. Response of T- and B-lymphocytes in the spleen of mammary tumor-bearing rats to treatment with tamoxifen and soluble tumor-associated antigens.
Ben-Hur H; Kossoy G; Sanko H; Geva D; Shumlin N; Zusman I; Elhayany A
Oncol Rep; 2004 Jul; 12(1):181-5. PubMed ID: 15201981
[TBL] [Abstract][Full Text] [Related]
12. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
13. Role of tamoxifen in the induction of hormone-independent rat mammary tumors.
Fendl KC; Zimniski SJ
Cancer Res; 1992 Jan; 52(1):235-7. PubMed ID: 1727383
[TBL] [Abstract][Full Text] [Related]
14. Human soluble p66 and p51 tumor-associated antigens promote the suppression of rat mammary tumors in comparison to commercial human albumin.
Kossoy G; Avinoach I; Zusman I; Scheider DP; Ben-Hur H; Elhayany A
Oncol Rep; 2004 Feb; 11(2):487-91. PubMed ID: 14719088
[TBL] [Abstract][Full Text] [Related]
15. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
[TBL] [Abstract][Full Text] [Related]
17. Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring.
Halakivi-Clarke L; Cho E; Onojafe I; Liao DJ; Clarke R
Clin Cancer Res; 2000 Jan; 6(1):305-8. PubMed ID: 10656462
[TBL] [Abstract][Full Text] [Related]
18. Proliferation of ductal outgrowths by carcinogen-induced rat mammary tumors in gland-free mammary fat pads.
Rivera EM; Vijayaraghavan S
J Natl Cancer Inst; 1982 Aug; 69(2):517-25. PubMed ID: 6810006
[TBL] [Abstract][Full Text] [Related]
19. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
20. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
